IntraDose-CDDP injectable gel of cisplatin: Began Phase II trial to detect histologic evidence of a clinical response in patients who will have their prostates

Matrix Pharmaceutical Inc. (MATX), Menlo Park, Calif. Product: IntraDose-CDDP injectable gel of cisplatin Indication: Prostate cancer Status: Began Phase II trial to detect histologic evidence of a cl...